Connect with us

Legal & Regulation

Former Head of FDA Scott Gottlieb Proposes Regulatory Plan for CBD

Published

on

Scott Gottlieb, the former commissioner of the U.S. Food and Drug Administration, presented his potential regulatory scheme concerning CBD last week. During the presentation, he posed the question of whether the FDA can oversee the quality of the substance, along with its purity and potency.

Gottlieb first recommended generating regulations for CBD supplements. Although they have become widely available, the cannot be marketed because the FDA has not developed rules concerning their marketing. He also added that regulators could place the onus on CBD producers to ensure that the products are safe at low levels and that manufacturing standards, purity, and minimum levels are being adhered to.

He also touched upon the safety of the products, stating that it must be the first principle, and that appropriate claims must be grounded in science. He also added that CBD is not safe and has largely unproven benefits outside a small subset of carefully studied indications.

At this point, there is no indication as to whether the FDA will issue an interim final rule, or what regulations will be implemented at all.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.